Issue · Technology

Technology

Every technology bill, vote, and legislator stance in Oklahoma, automatically classified by Maddy, our AI policy reader.

Total bills
11
2026 Regular Session
Top supporter
Josh West
91% support rate
Top opponent
Justin Humphrey
17% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving technology in Oklahoma

Legislators moving technology in Oklahoma
Legislator Party Stance Support rate Votes
Josh West
Josh West House · District 5
R
Strong +
91% 140
Ken Luttrell
Ken Luttrell House · District 37
R
Strong +
90% 127
Mike Osburn
Mike Osburn House · District 81
R
Strong +
90% 173
Mark Mann
Mark Mann Senate · District 46
D
Strong +
89% 165
Toni Hasenbeck
Toni Hasenbeck House · District 65
R
Strong +
88% 151
Justin Humphrey
Justin Humphrey House · District 19
R
Strong −
17% 102
Julie McIntosh
Julie McIntosh Senate · District 3
R
Strong −
17% 142
Brian Guthrie
Brian Guthrie Senate · District 25
R
Strong −
18% 149
Gabe Woolley
Gabe Woolley House · District 98
R
Strong −
19% 180
Tom Gann
Tom Gann House · District 8
R
Strong −
19% 163
Showing 11–11 of 11 bills

All technology bills

signed · Oklahoma · Senate May 5, 2025

SB 552: Public safety; prohibiting state agencies from certain use of biotechnology. Effective date.

Oklahoma's SB 552 bans state agencies that receive federal or state funds from using biotechnology equipment or services from companies designated by the federal government as "biotechnology companies of concern" (entities controlled by foreign adversaries posing national security risks through multiomics data collection). The bill specifically targets the use of multiomics technology - which combines data from genomics, proteomics, and other biological research areas - to prevent potential security threats. State agencies cannot contract with entities using such biotechnology, and the law only takes effect after a comparable federal law is enacted. This directly affects all Oklahoma state agencies managing federal or state funds, requiring them to avoid specific biotech vendors.
Showing 11 to 11 of 11 bills